SCHEMBL7869178

SCHEMBL7869178

CC(C)S(N)(=O)=O.CCCCN(CCc1ccccc1)Cc1ccc(C(=O)N[C@@H](CCSC)C(=O)O)c(-c2ccccc2C)c1

nearest known ligand 0.69

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FNTA P49354 5/20 0.69
FNTB P49356 5/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7869184 1.00 FNTA (0.69) FNTAFNTB
SCHEMBL6626875 0.94 FNTA (0.77) FNTAFNTB
SCHEMBL6626881 0.94 FNTA (0.77) FNTAFNTB
P-Toluenesulfonamide SCHEMBL6645582 0.92 FNTA (0.66) FNTAFNTB
Mafenide SCHEMBL6673073 0.92 FNTA (0.66) FNTAFNTB
P-Toluenesulfonamide SCHEMBL6645570 0.92 FNTA (0.66) FNTAFNTB
Mafenide SCHEMBL6673088 0.92 FNTA (0.66) FNTAFNTB
P-Toluenesulfonamide SCHEMBL7870326 0.91 FNTA (0.66) FNTAFNTB
Mafenide SCHEMBL7862566 0.91 FNTA (0.66) FNTAFNTB
Mafenide SCHEMBL7862561 0.91 FNTA (0.66) FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310095-B1 INHIBITING OR TREATING CANCER, TREATING INTIMAL HYPERPLASIA ASSOCIATED WITH RESTENOSIS AND ATHEROSCLEROSIS, INHIBITING POST-TRANSLATIONAL MODIFICATION OF ONCOGENIC RAS PROTEIN BY PROTEIN FARNESYLTRANSFERASE AND/OR GERANYLGERANYLTRANSFERASE UNIVERSITY OF PITTSBURGH 2001-10-30 US disclosed